Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CG Stock Summary
Top 10 Correlated ETFs
CG
In the News

Final Trades: Halliburton, Carlyle, & more
The "Halftime Report" traders give their top picks to watch for the second half.

Carlyle (CG) Rides on Organic Growth Despite Rising Expenses
A rise in AUM, and efforts to scale investment platforms and operations will drive Carlyle's (CG) organic growth amid rising incentive fee-related compensation.

Wall Street's Most Accurate Analysts Say Buy These 3 Financial Stocks With Over 4% Dividend Yields - Carlyle Group (NASDAQ:CG), Ally Financial (NYSE:ALLY)
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Carlyle (CG) Reduces Pan-Asia PE Fund Goal on Macro Slowdown
Carlyle Group (CG) reduces its pan-Asia PE fund target by around 30% from $8.5 billion.

McDonald's to acquire Carlyle's minority stake in McDonald's China
McDonald's Corp. MCD said Monday it has agreed to acquire Carlyle's CG minority stake in the partnership that operates and manages its business in Mainland China, Hong Kong and Macau. The fast food giant said the CITIC Consortium will retain its controlling stake but McDonald's will boost its stake to 48% from 20%.

Billionaire Investor Says 'Buy REITs': Our Top Picks
Barry Sternlicht is very bullish on REITs. Valuations are the lowest in years, and he is buying. We present three of our Top Picks to profit.

The Carlyle Group Inc. (CG) Q3 2023 Earnings Call Transcript
The Carlyle Group Inc. (NASDAQ:CG ) Q3 2023 Results Conference Call November 7, 2023 8:30 AM ET Company Participants Daniel Harris - Head of Investor Relations Harvey Schwartz - Chief Executive Officer John Redett - Chief Financial Officer Conference Call Participants Patrick Davitt - Autonomous Research Alex Blostein - Goldman Sachs Craig Siegenthaler - Bank of America Ken Worthington - JPMorgan Glenn Schorr - Evercore ISI Michael Cyprys - Morgan Stanley Brennan Hawken - UBS Brian Bedell - Deutsche Bank Brian Mckenna - JMP Securities Steven Chubak - Wolfe Research Dan Fannon - Jefferies Ben Budish - Barclays Operator Good day and thank you for standing by. Welcome to the Carlyle Group Third Quarter 2023 Earnings Conference Call.

Election Day: What to watch in Virginia's races — and why
Americans are going to the polls Tuesday in states including Ohio, Kentucky and Mississippi, but one state in particular stands out for its potential impact on the presidential race: Virginia.

Unveiling Carlyle (CG) Q3 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Carlyle (CG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2023.

Carlyle to sell Japanese cosmetics supplier Tokiwa in $1 bln deal -sources
Carlyle Group is planning to sell Japanese cosmetics supplier Tokiwa Corp in a deal that could fetch $1 billion, two sources with knowledge of the matter said.
CG Financial details
CG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.96 | 22.07 | 5.23 | 15.25 | 9.18 | |
Net income per share | 1.03 | 9.67 | 0.97 | 8.2 | 3.35 | |
Operating cash flow per share | -3.03 | 2.93 | -0.47 | 4.94 | -1.04 | |
Free cash flow per share | -3.31 | 2.7 | -0.64 | 4.82 | -2.84 | |
Cash per share | -22.91 | 7.48 | 3.17 | 7.21 | 4.35 | |
Book value per share | 25.04 | 5.05 | 7.49 | 14.55 | 17.01 | |
Tangible book value per share | 40.59 | 23.74 | 8.03 | 15.63 | 16.2 | |
Share holders equity per share | 25.04 | 5.05 | 7.49 | 14.55 | 17.01 | |
Interest debt per share | 61.51 | 61 | 23.69 | 24.95 | 24.62 | |
Market cap | 1.78B | 3.93B | 11.29B | 19.92B | 10.91B | |
Enterprise value | 7.3B | 9.98B | 18.2B | 25.8B | 18.02B | |
P/E ratio | 15.32 | 3.32 | 32.41 | 6.7 | 8.91 | |
Price to sales ratio | 0.99 | 1.45 | 6.01 | 3.6 | 3.25 | |
POCF ratio | -5.19 | 10.95 | -66.7 | 11.12 | -28.77 | |
PFCF ratio | -4.76 | 11.87 | -48.98 | 11.38 | -10.51 | |
P/B Ratio | 0.63 | 6.35 | 4.2 | 3.77 | 1.75 | |
PTB ratio | 0.63 | 6.35 | 4.2 | 3.77 | 1.75 | |
EV to sales | 4.04 | 3.69 | 9.7 | 4.66 | 5.37 | |
Enterprise value over EBITDA | 16.53 | 20.15 | 30.46 | 6.44 | 9.63 | |
EV to operating cash flow | -21.25 | 27.84 | -107.55 | 14.4 | -47.51 | |
EV to free cash flow | -19.47 | 30.18 | -78.98 | 14.75 | -17.36 | |
Earnings yield | 0.07 | 0.3 | 0.03 | 0.15 | 0.11 | |
Free cash flow yield | -0.21 | 0.08 | -0.02 | 0.09 | -0.1 | |
Debt to equity | 2.37 | 11.73 | 3.07 | 1.66 | 1.4 | |
Debt to assets | 0.46 | 0.53 | 0.53 | 0.41 | 0.41 | |
Net debt to EBITDA | 12.49 | 12.22 | 11.57 | 1.47 | 3.8 | |
Current ratio | 3.29 | 3.56 | 5.23 | 8.26 | 4.16 | |
Interest coverage | 1.6 | 2.01 | 2.12 | 13.56 | 5.36 | |
Income quality | -1.04 | 0.3 | -0.44 | 0.59 | -0.3 | |
Dividend Yield | 0.09 | 0.04 | 0.03 | 0.02 | 0.04 | |
Payout ratio | 1.32 | 0.15 | 1.01 | 0.12 | 0.36 | |
Sales general and administrative to revenue | 0.25 | 0.18 | 0.19 | 0.08 | 0.17 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0.04 | |
Capex to operating cash flow | 0.09 | -0.08 | 0.36 | -0.02 | 1.74 | |
Capex to revenue | -0.02 | -0.01 | -0.03 | -0.01 | -0.2 | |
Capex to depreciation | -0.67 | -0.42 | -1.17 | -0.8 | -4.47 | |
Stock based compensation to revenue | 0.18 | 0.05 | 0.06 | 0.03 | 0.05 | |
Graham number | 24.07 | 33.16 | 12.79 | 51.82 | 35.81 | |
ROIC | 0.04 | 0.05 | 0.03 | 0.21 | 0.09 | |
Return on tangible assets | 0.01 | 0.09 | 0.02 | 0.14 | 0.06 | |
Graham Net | -108.02 | -78.91 | -31.5 | -34.56 | -34.13 | |
Working capital | 1.01B | 909.2M | 1.21B | 2.76B | 1.57B | |
Tangible asset value | 4.61B | 2.91B | 2.88B | 5.67B | 5.92B | |
Net current asset value | -8.62B | -9.58B | -11.22B | -12.41B | -12.52B | |
Invested capital | 2.37 | 11.73 | 3.07 | 1.66 | 1.4 | |
Average receivables | 442.2M | 462.4M | 354.95M | 440M | 599.85M | |
Average payables | 398.65M | 398.55M | 320.6M | 333M | 374.45M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 116.35 | 47.04 | 70.33 | 34.21 | 74.11 | |
Days payables outstanding | 76.47 | 0 | 0 | 28.05 | 27.28 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.14 | 7.76 | 5.19 | 10.67 | 4.92 | |
Payables turnover | 4.77 | 0 | 0 | 13.01 | 13.38 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 1.91 | 0.13 | 0.56 | 0.2 | |
Capex per share | -0.28 | -0.23 | -0.17 | -0.11 | -1.8 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.23 | 1.78 | 2.37 | 1.21 | 1.74 | |
Net income per share | 0.77 | 0.35 | 0.28 | -0.27 | 0.23 | |
Operating cash flow per share | 0.82 | -0.33 | -0.31 | -2.04 | 2.22 | |
Free cash flow per share | 0.8 | -0.38 | -0.35 | -2.09 | 2.17 | |
Cash per share | 4.41 | 4.38 | 2.78 | 2.41 | 3.52 | |
Book value per share | 16.78 | 17.13 | 17.01 | 16.51 | 16.42 | |
Tangible book value per share | 15.71 | 16.31 | 16.38 | 16.08 | 15.83 | |
Share holders equity per share | 16.78 | 17.13 | 17.01 | 16.51 | 16.42 | |
Interest debt per share | 22.85 | 24.19 | 24.66 | 26.06 | 25.86 | |
Market cap | 9.42B | 10.83B | 11.27B | 11.54B | 10.87B | |
Enterprise value | 16.14B | 17.95B | 18.89B | 19.42B | 18.45B | |
P/E ratio | 8.39 | 21.3 | 27.99 | -29.33 | 33.44 | |
Price to sales ratio | 11.58 | 16.74 | 13.12 | 26.41 | 17.34 | |
POCF ratio | 31.41 | -89.69 | -100.2 | -15.67 | 13.6 | |
PFCF ratio | 32.23 | -79.43 | -89.9 | -15.27 | 13.89 | |
P/B Ratio | 1.54 | 1.74 | 1.83 | 1.94 | 1.84 | |
PTB ratio | 1.54 | 1.74 | 1.83 | 1.94 | 1.84 | |
EV to sales | 19.83 | 27.72 | 21.99 | 44.43 | 29.4 | |
Enterprise value over EBITDA | 35.58 | 87.71 | 983.88 | -86.92 | 663.51 | |
EV to operating cash flow | 53.79 | -148.55 | -167.92 | -26.37 | 23.06 | |
EV to free cash flow | 55.18 | -131.56 | -150.64 | -25.68 | 23.57 | |
Earnings yield | 0.03 | 0.01 | 0.01 | -0.01 | 0.01 | |
Free cash flow yield | 0.03 | -0.01 | -0.01 | -0.07 | 0.07 | |
Debt to equity | 1.35 | 1.4 | 1.43 | 1.56 | 1.55 | |
Debt to assets | 0.39 | 0.41 | 0.42 | 0.43 | 0.44 | |
Net debt to EBITDA | 14.8 | 34.75 | 396.74 | -35.26 | 272.33 | |
Current ratio | 2.62 | 4.16 | 3.67 | 11.18 | 4.73 | |
Interest coverage | 5.07 | 1.55 | 2.7 | -1.68 | 0.21 | |
Income quality | 1.06 | -0.76 | -0.9 | 11.75 | 7.21 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.42 | 0.93 | 1.18 | -1.29 | 1.55 | |
Sales general and administrative to revenue | 0.18 | 0.29 | 0.19 | 0.39 | 0.23 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.03 | 0.13 | 0.11 | 0.03 | -0.02 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.04 | -0.03 | |
Capex to depreciation | -0.18 | -0.35 | -0.29 | -0.44 | -0.35 | |
Stock based compensation to revenue | 0.17 | 0.02 | 0.06 | 0 | 0 | |
Graham number | 17.05 | 11.62 | 10.31 | 10.06 | 9.13 | |
ROIC | 0.02 | 0.01 | 0.01 | -0.01 | 0 | |
Return on tangible assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Graham Net | -33.96 | -34.37 | -35.82 | -36.88 | -34.86 | |
Working capital | 1.25B | 1.57B | 1.1B | 1.34B | 1.54B | |
Tangible asset value | 5.73B | 5.92B | 5.95B | 5.81B | 5.71B | |
Net current asset value | -12.41B | -12.52B | -12.95B | -13.26B | -12.5B | |
Invested capital | 1.35 | 1.4 | 1.43 | 1.56 | 1.55 | |
Average receivables | 602.8M | 638.15M | 640.6M | 661.2M | 771.25M | |
Average payables | 347.2M | 374.3M | 337M | 316.15M | 295.5M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 65.81 | 94.73 | 62.85 | 148.76 | 117.65 | |
Days payables outstanding | 47.37 | 6.73 | 40.31 | 57.01 | 43.45 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.37 | 0.95 | 1.43 | 0.6 | 0.77 | |
Payables turnover | 1.9 | 13.38 | 2.23 | 1.58 | 2.07 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | 0.02 | 0.02 | -0.02 | 0.01 | |
Capex per share | -0.02 | -0.04 | -0.04 | -0.05 | -0.05 |
CG Frequently Asked Questions
What is The Carlyle Group Inc. stock symbol ?
The Carlyle Group Inc. is a US stock , located in Washington of Dc and trading under the symbol CG
Is The Carlyle Group Inc. buy or a sell ?
19 stock analysts have 19 predictions with a medium analyst target price of $48.95. The lowest prediction is $30 and the highest is $80
What is CG stock prediction ?
With a median analyst target price of $39, 1 stock analysts have made 1 forecasts in last 90 days. $39 is the lowest and $39 is the greatest projection.
What is The Carlyle Group Inc. stock quote today ?
The Carlyle Group Inc. stock price is $34.43 today.
Is The Carlyle Group Inc. stock public?
Yes, The Carlyle Group Inc. is a publicly traded company.